You are here

  • Home
  • Archive
  • Volume 6, Issue 2
  • 2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials

Article Text

Article menu
Download PDFPDF
Commentary
2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials

https://doi.org/10.1136/neurintsurg-2013-010665

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors All authors contributed to the composition and/or critical review of the manuscript.

    • Competing interests MG is a consultant for Covidien/ev3 and serves as a co-principal investigator for SWIFT-PRIME and ESCAPE trials. AST has research grants or consulting agreements with Stryker, Microvention, Penumbra and Codman. JM serves as a consultant for Lazarus Effect and Nfocus and has investor interests in Blockade Medical. DSL serves as a consultant for Stryker and Covidien. AMD has received honoraria from Covidien. All other authors have no disclosures to report.

    • Provenance and peer review Not commissioned; internally peer reviewed.